- Home
- ARCB vs SUPN Comparison
ARCB vs SUPN Comparison
Compare ARCB & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- SUPN
- Stock Information
- Founded
- ARCB 1923
- SUPN 2005
- Country
- ARCB United States
- SUPN United States
- Employees
- ARCB N/A
- SUPN N/A
- Industry
- ARCB Trucking Freight/Courier Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- ARCB Industrials
- SUPN Health Care
- Exchange
- ARCB Nasdaq
- SUPN Nasdaq
- Market Cap
- ARCB 1.9B
- SUPN 1.7B
- IPO Year
- ARCB N/A
- SUPN 2012
- Fundamental
- Price
- ARCB $69.49
- SUPN $32.72
- Analyst Decision
- ARCB Buy
- SUPN Hold
- Analyst Count
- ARCB 13
- SUPN 2
- Target Price
- ARCB $107.00
- SUPN $36.00
- AVG Volume (30 Days)
- ARCB 314.6K
- SUPN 704.1K
- Earning Date
- ARCB 04-29-2025
- SUPN 05-07-2025
- Dividend Yield
- ARCB 0.68%
- SUPN N/A
- EPS Growth
- ARCB N/A
- SUPN 6500.00
- EPS
- ARCB 7.31
- SUPN 1.32
- Revenue
- ARCB $4,179,019,000.00
- SUPN $661,817,000.00
- Revenue This Year
- ARCB $4.67
- SUPN N/A
- Revenue Next Year
- ARCB $7.02
- SUPN $8.67
- P/E Ratio
- ARCB $9.73
- SUPN $24.46
- Revenue Growth
- ARCB N/A
- SUPN 8.94
- 52 Week Low
- ARCB $68.83
- SUPN $25.53
- 52 Week High
- ARCB $153.60
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- ARCB 29.98
- SUPN 45.99
- Support Level
- ARCB $72.77
- SUPN $31.74
- Resistance Level
- ARCB $75.08
- SUPN $33.56
- Average True Range (ATR)
- ARCB 2.60
- SUPN 0.91
- MACD
- ARCB 0.48
- SUPN 0.26
- Stochastic Oscillator
- ARCB 9.89
- SUPN 62.82
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.